A password will be e-mailed to you.

Maricann also revealed that the OSC began investigating CEO Ben Ward on Feb. 8. (THE CANADIAN PRESS/Graeme Roy) Shares of medical marijuana producer Maricann plunged 21 per cent on Wednesday after it revealed that a $70 million financing deal had been cancelled as it faces an investigation from the country’s biggest securities regulator. Underwriters for a group of investment banks “orally” told the company that they will no longer go ahead with a share sale or bought deal that would have raised $70 million for Maricann, it said in a statement.  The firm also said that several executives are being investigated by the Ontario Securities Commission (OSC) for the “timing and reporting of certain trades” of shares owned or controlled by directors Neil Tabatznik, Raymond Stone and Eric Silver. “Stone, Tabatznik and Silver have advised the company that they are fully cooperating with the OSC in its review,” the firm said. Both Tabatznik and Stone have resigned from the small cannabis producer in light of the probe. Marijuana producer Maricann shares plunge on news of trading probe

thumbnail courtesy of www.cbc.ca

No more articles